Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Terns Pharmaceuticals (TERN) Income from Non-Controlling Interests (2020)

Terns Pharmaceuticals' Income from Non-Controlling Interests history spans 1 years, with the latest figure at -$28000.0 for Q4 2020.

  • For Q4 2020, Income from Non-Controlling Interests changed N/A year-over-year to -$28000.0; the TTM value through Jun 2021 reached -$313000.0, changed N/A, while the annual FY2020 figure was -$518000.0, N/A changed from the prior year.
  • Income from Non-Controlling Interests reached -$28000.0 in Q4 2020 per TERN's latest filing, up from -$128000.0 in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$28000.0 in Q4 2020 to a low of -$205000.0 in Q1 2020.